LEADER 05903nam 2202101z- 450 001 9910557432103321 005 20210501 035 $a(CKB)5400000000043402 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68462 035 $a(oapen)doab68462 035 $a(EXLCZ)995400000000043402 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aRole of Medical Imaging in Cancers 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 210 1$aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (312 p.) 311 08$a3-0365-0180-0 311 08$a3-0365-0181-9 330 $aundefined 606 $aMedicine$2bicssc 610 $a18F-FACBC 610 $a18F-FDG PET/CT 610 $a68Gallium-PSMA PET/CT 610 $aadipose tissue 610 $aAdoptive 610 $abiochemical recurrence 610 $abiomarker 610 $abiomarkers 610 $abladder cancer 610 $abreast 610 $abreast cancer 610 $acastrate resistant prostate cancer 610 $aCD8-Positive T-Lymphocytes 610 $acirculating miRNAs 610 $acirculating tumor cells 610 $acomputed tomography 610 $aComputer-assisted diagnosis 610 $aconcurrent chemoradiotherapy 610 $aconsensus 610 $aCTLA-4 Antigen 610 $acystic tumor 610 $aDCFBC 610 $aDCFPyL 610 $aDeauville criteria 610 $adiagnosis 610 $adiagnostic imaging 610 $adiffuse large B-cell lymphoma 610 $adiffusion 610 $adiffusion kurtosis imaging 610 $adiffusion tensor imaging 610 $adiffusion-weighted imaging 610 $adynamic 18F-FDG PET/CT 610 $adynamic contrast-enhanced magnetic resonance imaging 610 $aEBV 610 $aempyema 610 $aepistemology 610 $aFDG 610 $aFDG-PET/CT 610 $afollow up 610 $aglioblastoma 610 $agold nanoparticle 610 $aguidelines 610 $ahead and neck cancer 610 $ahead and neck neoplasms 610 $aheat shock protein 70 610 $aHodgkin lymphoma 610 $aHounsfield unit 610 $aHPV 610 $aimaging 610 $aimaging parameters 610 $aimmune checkpoint inhibitors 610 $aimmunotherapy 610 $aImmunotherapy 610 $aInternational Consensus Guidelines 610 $aintraductal papillary mucinous neoplasms 610 $alocally advanced cervical cancer 610 $amachine learning 610 $amagnetic resonance imaging 610 $amalignant pleural mesothelioma 610 $amantle cell lymphoma 610 $amarker 610 $amCRPC 610 $ameningioma 610 $aMesothelin 610 $ameta-analysis 610 $ametastatic breast cancer 610 $amiRNA expression 610 $amolecular imaging 610 $aMolecular imaging 610 $aMRI 610 $an/a 610 $aneovascularization 610 $aneuroimaging 610 $anon-small-cell lung cancer 610 $anoninvasive imaging 610 $aNSCLC 610 $anuclear medicine 610 $aoptimal cutoff level 610 $aovarian cancer 610 $aoverutilization 610 $ap16 610 $apancreatic neoplasms 610 $apathologic 610 $apazopanib 610 $aPD-1 610 $aPD-L1 610 $aPDAC 610 $aPERCIST 610 $aperfusion 610 $aPET 610 $aPET/CT 610 $aPET/MRI 610 $aPI-RADS 610 $apleural dissemination 610 $apleural effusion 610 $apositron emission tomography 610 $apositron-emission tomography 610 $aprecision oncology 610 $aprognosis 610 $aprogrammed cell death 1 receptor 610 $aprostate 610 $aprostate cancer 610 $aprostate-specific-antigen 610 $aPSA kinetics thresholds 610 $aPSMA 610 $aPSMA-1007 610 $aradiation therapy 610 $aradioactive tracers 610 $aradiogenomics 610 $aradiomic 610 $aradiomics 610 $aradionuclide imaging 610 $aradionuclide therapy 610 $aRadium-223 610 $areceptor status 610 $arecurrence 610 $arelapse 610 $aresponse assessment 610 $aresponse to therapy 610 $aresponse to treatment 610 $areview 610 $asdAbs 610 $asingle-photon emission computed tomography 610 $asoft tissue sarcoma (STS) 610 $asomatostatin receptor 610 $aSPECT imaging 610 $aSPECT/CT 610 $aspectral-CT 610 $asquamous cell carcinoma of the head and neck 610 $astaging 610 $asurvival 610 $aSUV 610 $aSUVmax 610 $atargeted therapy 610 $atexture analysis 610 $aTherapy response assessment 610 $atreatment response 610 $atriple negative breast cancer 610 $atwo-tissue compartment model 610 $aupper tract urothelial carcinoma 610 $aurothelial carcinoma 610 $aVCAM-1 610 $aXOFIGO 610 $aYin Yang 1 615 7$aMedicine 700 $aFanti$b Stefano$4edt$0755618 702 $aEvangelista$b Laura$4edt 702 $aFanti$b Stefano$4oth 702 $aEvangelista$b Laura$4oth 906 $aBOOK 912 $a9910557432103321 996 $aRole of Medical Imaging in Cancers$93024548 997 $aUNINA LEADER 04537nam 2201129z- 450 001 9910557338903321 005 20220111 035 $a(CKB)5400000000042489 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76565 035 $a(oapen)doab76565 035 $a(EXLCZ)995400000000042489 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aInnovative Production Strategies for High-Quality, Traditional Pig Products 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (204 p.) 311 08$a3-0365-1400-7 311 08$a3-0365-1399-X 330 $aIn a number of European countries (e.g., Spain, Italy, France, Portugal, Slovenia, Croatia, Poland), a portion of the pig sector is aimed at the production of traditional and certified products (e.g., PDO-Protected Designation of Origin, PGI-Protected Geographical Indication). Dry-cured ham is probably the most famous traditional pork product; however, typical pork products are produced in (and exported to) many countries worldwide. The meat used for producing these high-quality delicacies needs to be suitable for seasoning and dry-curing, and these characteristics are the result of complex interactions between the animal (breed, genotype, rearing condition, feeding regime, age and weight at slaughter, etc.) and the environment, without disregarding the importance of ethical attributes such as animal welfare and the environmental impact.This Special Issue focuses on all the innovative production strategies for pigs intended for high-quality, typical productions (in term of higher sustainability of the whole production chain, improvement of animal welfare, innovative feeding and farming techniques, reduction in environmental impact, improvement in meat and fat quality, etc.), with emphasis on PDOs, PGIs, and other recognized production schemes, and it is aimed at providing new insights for a wide range of stakeholders from different countries. 606 $aBiology, life sciences$2bicssc 606 $aResearch & information: general$2bicssc 606 $aTechnology, engineering, agriculture$2bicssc 610 $aadipose tissue 610 $aaggression 610 $aagonistic behavior 610 $aAlentejano 610 $aaltitude 610 $aamino acid 610 $aanimal welfare 610 $aaroma 610 $aautophagy 610 $aBi?saro 610 $acarcass 610 $acarcass quality 610 $acastration 610 $aCinta Senese pig 610 $acuring agents 610 $adarkness 610 $adifferentiation 610 $adorsal subcutaneous fat 610 $adry-cured ham 610 $aentire male 610 $aextensive system 610 $afatty acid 610 $afatty acids 610 $afatty-acid profile 610 $agenetic marker 610 $aham processing 610 $aham quality 610 $aIberian pig 610 $aIberian pork 610 $aimmunocastration 610 $ain-depth interviews 610 $aintramuscular preadipocyte 610 $aLiangshan pig 610 $alight 610 $alipogenic enzymes 610 $alncIMF4 610 $alow-protein diet 610 $amass spectrometry 610 $ameat 610 $ameat quality 610 $amixing 610 $anatural extract 610 $aphotoperiod 610 $apig 610 $apigs 610 $aplasma hormones 610 $apork 610 $apork quality 610 $aqualitative analysis 610 $aquality standard 610 $aregrouping 610 $aRibatejano 610 $asausages 610 $askin lesions 610 $asolid-phase microextraction 610 $astress 610 $aSus scrofa 610 $aswine 610 $atraditional pig products 610 $atransport 615 7$aBiology, life sciences 615 7$aResearch & information: general 615 7$aTechnology, engineering, agriculture 700 $aMartelli$b Giovanna$4edt$01322273 702 $aNannoni$b Eleonora$4edt 702 $aMartelli$b Giovanna$4oth 702 $aNannoni$b Eleonora$4oth 906 $aBOOK 912 $a9910557338903321 996 $aInnovative Production Strategies for High-Quality, Traditional Pig Products$93034741 997 $aUNINA